首页> 外文期刊>Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] >Predictive biomarkers for acute gallstone pancreatitis in the pediatric population
【24h】

Predictive biomarkers for acute gallstone pancreatitis in the pediatric population

机译:儿科人群中急性胆石胰腺炎的预测生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundEarly biomarkers for diagnosis of gallstone pancreatitis (GP) in pediatrics have not been well studied. Reliably differentiating GP from other causes of acute pancreatitis (AP) would allow for early diagnosis and prompt management. We sought to assess biomarkers and clinical variables for early GP diagnosis from a prospectively-enrolled registry of pediatric patients presenting with first AP episode. MethodsCross-sectional analysis of a prospective acute pancreatitis registry of children enrolled from March 2013 through October 2016 was performed. Fisher's exact test and Wilcoxon rank sum test were used to compare demographic and clinical variables between GP and non-GP groups. A multivariable logistic regression model was derived, and receiver operating characteristic (ROC) curve was built using stepwise selection. Results114 subjects were enrolled (21 with GP, 93 as non-GP). Median was statistically higher for GP patients in lipase values X upper limit of normal (ULN) on admission, weight percentile for age, alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transferase. By multivariable analysis, significant predictors were ALT and Lipase xULN. A model built using these two variables for prediction of GP identified an AUROC of 0.85. At a predictive probability of 0.35, the model had an 80% sensitivity, 93% specificity, 76% positive predictive value and 95% negative predictive value. ConclusionsWe have developed a model for predicting GP in children that could help guide clinical management of AP patients. Future studies are needed to validate use of laboratory findings and clinical variables in evaluation of gallstone etiology in pediatric AP patients.
机译:背景下的胆石胰腺炎(GP)的背景性生物标志物尚未得到很好的研究。可靠地区分GP与急性胰腺炎(AP)的其他原因会允许早期诊断和及时管理。我们试图评估生物标志物和早期GP诊断的生物标志物和临床变量,从第一个AP剧集的儿科患者注册的儿科患者注册登记型诊断。方法对2013年3月至2016年10月招募的儿童预期急性胰腺炎注册表的译分分析。 Fisher的确切测试和Wilcoxon等级和测试用于比较GP和非GP组之间的人口统计和临床变量。导出多变量逻辑回归模型,使用逐步选择构建接收器操作特性(ROC)曲线。结果114受试者注册(21例,GP,93例为非GP)。在脂肪酶价值X患者中,中位数在脂肪酶价值X患者的血液抑制患者患者(ULN)上的上限,体重百分位,丙氨酸氨基转移酶,天冬氨酸氨基转移酶和γ-戊二醇转移酶。通过多变量分析,显着的预测因子是ALT和脂肪酶XULN。使用这两个变量构建的模型,用于预测GP,确定了0.85的Auroc。在0.35的预测概率下,该模型具有80%的灵敏度,93%的特异性,76%的阳性预测值和95%的负预测值。结论我们已经开发了一种预测患儿GP的模型,可以帮助指导AP患者的临床管理。需要进行未来的研究来验证实验室发现和临床变量在儿科AP患者的胆结石病因评估中使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号